Egypt Puts the ‘Final Touches’ on Government's IPO Program

The Egyptian capital (Reuters)
The Egyptian capital (Reuters)
TT

Egypt Puts the ‘Final Touches’ on Government's IPO Program

The Egyptian capital (Reuters)
The Egyptian capital (Reuters)

Egypt is preparing to announce a considerable program of public offerings soon and is putting the final touches ahead of providing a comprehensive program with international standards that attract investments.

During the past months, authorities postponed several IPOs because of bad timing during a widespread economic downturn or a disagreement between the Egyptian government and foreign investors on the offerings.

The currency value is the biggest reason for the recent disagreements. A wide gap between the dollar price in the official and parallel markets, which sometimes reached about 30 percent, played a significant factor in the divergence of views.

Official ministerial sources revealed to Asharq Al-Awsat that extensive work is underway to bridge the gaps that hindered understanding of the IPO program.

The sources that asked not to be named indicated that the final details are being worked out on the comprehensive program, which will be presented during a huge conference under high-level sponsorship.

Cairo needs to accelerate the program of government offerings amid a stressful economic situation due to the decline of foreign reserves, and before the due dates and interests of some of the debts.

According to the data, the proposals program may include about 32 state-owned companies in stages during the coming months, including three banks, four government real estate companies, several hotels under government management, and insurance, energy, and transportation companies.

The offerings could reportedly be led by the army-owned Wataniya and Safi companies, perhaps during the month of July.

Meanwhile, the head of the Egyptian Stock Exchange (EGX), Rami el-Dokany, indicated in a televised statement that there are talks with an extensive list of private companies to be listed on the stock exchange.

Dokany pointed out the focus on companies that have dollar resources, export their products, or work in energy and tourism.

However, Bank of America's head of EMEA equity capital markets, James Palmer, said he believed foreign investors continue to have appetite for Middle East IPOs.

"The pipeline is encouraging although we are not expecting a huge wave for the second half. Many situations are more focused on early or mid next year, rather than the back end of this year," said Palmer.

Some Middle Eastern issuers "feel very good about a belief in the structural shift in the region, broadly defined; that is, the commitment in the region to develop and advance the capital markets, and commitments from local entities to show financial support for them," he added.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.